Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 10/20 | 0.63 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.43 |
| ▸ | GLA | P06280 | 3/20 | 0.42 |
| ▸ | GAA | P10253 | 3/20 | 0.42 |
| ▸ | MAPT | P10636 | 3/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | NPC1 | O15118 | 2/20 | 0.42 |
| ▸ | RAB9A | P51151 | 2/20 | 0.42 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.41 |
| ▸ | SULT1A1 | P50225 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24038224 | 0.90 | APP (0.72) | APPDYRK1AGLAGAAMAPT | |
| SCHEMBL24332314 | 0.90 | APP (0.53) | APPDYRK1AGLAGAAMAPT | |
| SCHEMBL24332023 | 0.88 | APP (0.54) | APPDYRK1AGLAGAAMAPT | |
| SCHEMBL24038172 | 0.85 | APP (0.66) | APPGLAGAAMAPTKDM4E | |
| SCHEMBL24038173 | 0.84 | APP (0.62) | APPDYRK1AGLAGAAMAPT | |
| SCHEMBL24038171 | 0.83 | APP (0.63) | APPSULT1A1 | |
| SCHEMBL24332359 | 0.83 | APP (0.78) | APPDYRK1AGLAGAAMAPT | |
| SCHEMBL24332312 | 0.82 | APP (0.55) | APPDYRK1AGLAGAAMAPT | |
| SCHEMBL24332109 | 0.82 | APP (0.55) | APPDYRK1AGLAGAAMAPT | |
| SCHEMBL24037824 | 0.82 | APP (0.59) | APPGLAGAAMAPTKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021230512-A1 | BENZAZOLE DERIVATIVE, AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | 주식회사 랩토 | 2021-11-18 | — | — | WO | disclosed |